Lionco Pharmaceutical Group Co.,Ltd. (China)

Lionco Pharmaceutical Group Co., Ltd. is an innovative group enterprise that specializes in pharmaceutical research, production, and sales. Over the past decade, the company has become a high-tech and high-growth group enterprise with strong capabilities in the Chinese pharmaceutical industry. Lionco has received various honors and awards, including being recognized as a "National High-Tech Enterprise," "China New Industrialization Contribution Award," "China Patent Excellence Award," "Advanced Unit in Implementing Famous Brand Strategy," "Industrial Quality and Efficiency Demonstration Enterprise in Hainan Province," and "Innovative Enterprise in Haikou City." The company's leading products, such as "Injection Grade N-Acetylglutamine" and "Injection Grade Fructose," have been recognized as "National Key New Products" by the Ministry of Science and Technology, and the company has also received multiple "Scientific and Technological Progress Awards" for its pharmaceutical products. Lionco's trademarks, including "Xinkunchang" and "Ruiboqi," have been recognized as famous trademarks in Hainan Province by the provincial government. The company has 180 approvals and operates eight workshops, including general powder injection, cephalosporin powder injection, cephalosporin lyophilized powder injection, general lyophilized powder injection, small volume injection, oral solid preparation, cephalosporin raw material, and general raw material workshops, all of which have obtained national GMP certification. The company's lyophilization production line has reached international advanced and domestic leading levels in terms of technology and production capacity, and its pharmaceutical nutrition products hold a leading market share in the industry.